Corneal Disease: Clinical Trials

37 trials for Corneal Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 7 unknown, 4 recruiting, 3 terminated. 13 Not applicable, 7 Phase 1, 5 Phase 2, 2 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable13Completed 7, Terminated 2, Recruiting 1, Suspended 1, Unknown 1, Withdrawn 1
Phase 17Unknown 2, Withdrawn 2, Completed 1, Not yet recruiting 1, Recruiting 1
Phase 25Unknown 2, Completed 1, Not yet recruiting 1, Recruiting 1
Phase 42Unknown 2
Early Phase 11Completed 1

Follow Corneal Disease: new trials by email Literature Review of Corneal Disease trials Research Report on Corneal Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
CorNeat KPro - Corneal Disease, Corneal Opacity
Not applicableTerminatedCorNeat Vision Ltd.152024-06-272026-05-07
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.
20% ASED + AT, 0.9% NS + AT - Corneal Epitheliopathy, Glaucoma
Phase 4UnknownUniversité de Sherbrooke252024-03-012024-03-05
Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
Optical Coherence Tomography - Corneal Disease, Endothelial Corneal Dystrophy
CompletedNitin Vaswani192023-10-122026-02-19
Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain
Cord plasma eye drops - Neuropathic Pain, Corneal Disease
Not applicableRecruitingSingapore Eye Research Institute202023-09-162026-05-05
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone - Multiple Myeloma, Neoplasms
Phase 1 / Phase 2RecruitingHellenic Society of Hematology362023-07-142023-10-24
QST for Corneal Nerve Function
Quantitative Sensory Test - Corneal Disease, Neuropathy
Not applicableSuspendedTufts Medical Center1082023-05-162026-01-08
Prospective Study to Validate the Imaging Biomarker for NCP (R33)
In vivo confocal microscopy (IVCM) - Dry Eye Syndromes, Corneal Disease
SuspendedTufts Medical Center4382022-12-162026-01-07
NGF Treatment for Patients With Neuropathic Corneal Pain
Cenegermin-Bkbj - Corneal Disease, Neuropathy
Phase 1WithdrawnTufts Medical Center2022-11-012023-01-26
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide - Multiple Myeloma, Multiple Myeloma in Relapse
Phase 1 / Phase 2Not yet recruitingHellenic Society of Hematology482022-10-202022-10-17
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide - Multiple Myeloma, Neoplasms
Phase 1 / Phase 2UnknownHellenic Society of Hematology362022-04-132023-12-01
Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
Transepithelial Corneal Collagen Cross-linking, Scheimpflug camera - Keratoconus, Collagen Diseases
CompletedBenha University92021-10-092021-11-10
Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking
Xiidra 5% Ophthalmic Solution - Corneal Disease
Phase 4UnknownBenha University402021-02-012021-09-16
First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness
CorNeat KPro - Corneal Disease, Corneal Opacity
Not applicableTerminatedCorNeat Vision Ltd.102021-01-032024-09-24
Artificial Intelligence for Screening of Multiple Corneal Diseases
Cornea diseases diagnosed by artificial intelligence algorithm - Deep Learning, Corneal Disease
RecruitingTianjin Eye Hospital30002020-12-062024-11-04
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany), Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany), Optic nerve head measurement - Corneal Ectasia, Corneal Disease
CompletedTechnische Universität Dresden3722020-07-092022-08-11
Agreement and Precision Study of the Nidek Mirante
Nidek Mirante, Optovue RTVue XR Avanti, Optos P200DTx - Glaucoma, Retinal Disease
Not applicableCompletedNidek Co. LTD.1702020-01-252023-08-24
Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus
Epi-on PiXL, Epi-Off PiXL - Keratoconus, Corneal Crosslinking
Not applicableCompletedUmeå University322019-04-022023-09-01
Femtolaser Assisted Keratoplasty Versus Conventional Keratoplasty
Femtosecond Laser, Trephine blade - Keratoconus, Fuchs Dystrophy
Not applicableUnknownUniversity of Southampton302019-02-012020-12-22
Rapid Computerized Visual Acuity Test
Computerized visual acuity assessment program - Vision Disorders, Refractive Errors
UnknownRambam Health Care Campus2002019-01-012022-07-07
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops
Systane Complete, Systane Ultra - Dry Eye Syndromes, Keratoconjunctivitis Sicca
Not applicableCompletedOhio State University242018-12-052019-05-23

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Corneal Diseases (37)  ·  Glaucoma (6)  ·  Dry Eye Syndromes (5)  ·  Keratoconus (5)  ·  Retinal Diseases (5)  ·  Blood Protein Disorders (3)  ·  Cataract (3)  ·  Corneal Injuries (3)  ·  Corneal Opacity (3)  ·  Hematologic Diseases (3)  ·  Multiple Myeloma (3)  ·  Neoplasms (3)  ·  Neoplasms, Plasma Cell (3)  ·  Paraproteinemias (3)  ·  Astigmatism (2)

Broader conditions

Eye Diseases (35)  ·  Ocular Hypertension (6)  ·  Lacrimal Apparatus Diseases (5)  ·  Nervous System Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Cardiovascular Diseases (4)  ·  Conjunctival Diseases (4)  ·  Immune System Diseases (4)  ·  Vascular Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Craniocerebral Trauma (3)  ·  Eye Diseases, Hereditary (3)  ·  Eye Injuries (3)  ·  Facial Injuries (3)  ·  Genetic Diseases, Inborn (3)

Interventions

Dexamethasone (3)  ·  Corneal Cross-Linking (2)  ·  Corneal Topography (2)  ·  Lenalidomide (2)  ·  Tomography (2)  ·  daratumumab (2)  ·  Betamethasone (1)  ·  Contact Lenses (1)  ·  Levofloxacin (1)  ·  Mitomycin (1)  ·  Ophthalmic Solutions (1)  ·  Tomography, Optical Coherence (1)  ·  Vision, Ocular (1)  ·  cenegermin (1)  ·  lifitegrast (1)

Sponsors

National Eye Institute (NEI) (4)  ·  Benha University (3)  ·  Hellenic Society of Hematology (3)  ·  Nidek Co. LTD. (3)  ·  Tufts Medical Center (3)  ·  CorNeat Vision Ltd. (2)  ·  Technische Universität Dresden (2)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Federal University of São Paulo (1)  ·  Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1)  ·  Klinikum Klagenfurt am Wörthersee (1)  ·  LenSx Lasers Inc. (1)  ·  Nitin Vaswani (1)  ·  Ohio State University (1)

Countries

United States (15)  ·  China (3)  ·  France (3)  ·  Israel (3)  ·  Canada (2)  ·  Germany (2)  ·  Greece (2)  ·  Netherlands (2)  ·  United Arab Emirates (2)  ·  Austria (1)  ·  Belarus (1)  ·  Egypt (1)  ·  Italy (1)  ·  Singapore (1)  ·  Sweden (1)

Top investigators

Evangelos Terpos, Prof (3)  ·  Pedram Hamrah, MD (3)  ·  Ahmed A Tabl, MD (1)  ·  Anders Behndig, MD, PhD (1)  ·  Edward J Holland, MD (1)  ·  Eytan Z Blumenthal, MD (1)  ·  Frederik Raiskup, MD, PhD (1)  ·  Igor Volotovski, Prof (1)  ·  James F Hejtmancik, M.D. (1)  ·  Jonathan H Lass, MD (1)  ·  Liudmila Marchenko, Prof (1)  ·  Mark J Mannis, MD (1)  ·  Mona Harissi-Dagher, MD (1)

Results publications

PMID 14289827, PMID 15745770, PMID 15829793, PMID 16371775, PMID 16603465, PMID 18387407, PMID 18387408, PMID 19056078, PMID 19395036, PMID 19724216, PMID 20065219, PMID 21555600, PMID 22262218, PMID 22488114, PMID 23343949, PMID 23493999, PMID 24246825, PMID 24246826, PMID 25119961, PMID 25322173, PMID 25425307, PMID 25439611, PMID 28475702, PMID 32852646, PMID 34012881, PMID 34059127, PMID 35035046, PMID 35606839

NIH funding

R33NS113341 (1), U10EY012358 (1), U10EY012728 (1)